
News
|
Corning Announces Commercial Agreement with HighRes Biosolutions |
..................................................................................................................................................................................................................................
|
HighRes Biosolutions customer Burnham Institute Awarded $97.9 Million NIH Grant to Expand Small-Molecule Screening and Discovery Center |
..................................................................................................................................................................................................................................
|
HighRes Biosolutions customer Broad Institute awarded nearly $90M grant to develop chemical probes for human biology and disease |
..................................................................................................................................................................................................................................
| HighRes Biosolutions expands into Europe
May 6, 2008 FAST growing US life science automation company, HighRes Biosolutions, is expanding into Europe and is opening an office in the UK. HighRes, which was only formed a few years ago, is already the leading automation integrator for the pharmaceutical sector in the US and is busy developing a large suite of laboratory instruments. |
![]() |
..................................................................................................................................................................................................................................
The Burnham Institute selects HighRes Biosolutions' MicroCell for high-throughput screening automation
August 20, 2007
HighRes Biosolutions has just signed a major contract to supply the Burnham Institute for Medical Research (Burnham) with specialized equipment for storing and screening large biological libraries. To be installed at the Institute's Lake Nona, Orlando campus, the new three-pod system, the largest of its kind in the industry will fortify Burnham's bi-coastal research and drug discovery efforts, which include research on cancer, neurological diseases, aging, diabetes, and obesity, as well as other diseases.
(Read more...)



